Показано 0 из 0
Дата |
---|
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.394
|
0.478
|
0.382
|
0.382
|
0.382
|
0.382
|
|
|
|
|
0.402
|
0.47
|
0.38
|
0.38
|
0.38
|
0.38
|
|
|
|
|
0.404
|
0.472
|
0.414
|
0.414
|
0.414
|
0.414
|
|
|
|
|
0.406
|
0.474
|
0.424
|
0.424
|
0.424
|
0.424
|
|
|
|
|
0.422
|
0.494
|
0.434
|
0.434
|
0.434
|
0.434
|
|
|
|
|
|
|
0.414
|
0.414
|
0.414
|
0.414
|
|
|
|
|
0.418
|
0.494
|
0.404
|
0.404
|
0.404
|
0.404
|
|
|
|
|
0.416
|
0.496
|
0.408
|
0.408
|
0.408
|
0.408
|
|
|
|
|
0.412
|
0.494
|
0.426
|
0.426
|
0.426
|
0.426
|
|
|
|
|
0.416
|
0.51
|
0.454
|
0.454
|
0.454
|
0.454
|
|
|
|
|
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the epigenetic causes of cancers.